Massive companies managing prescriptions for millions of Americans must reveal their financial dealings with drugmakers due to a new Trump administration regulation. Pharmacy benefit managers, responsible for negotiating prescription drug benefits, must disclose payment details to enhance transparency and potentially lower drug costs.
Pharmacy benefit managers, like Express Scripts, Caremark, and Optum Rx, control about 80 percent of U.S. prescription drug claims. The new rule, effective from July, aims to address concerns that these managers exploit transparency gaps to guide patients toward pricier medications. This move targets drug cost reduction and transparency in the healthcare sector.
The Trump administration is ensuring no one in the healthcare industry can escape the competition that comes from complete price transparency. – Labor Secretary Keith Sonderling
The policy could enable employers to negotiate better deals for self-insured group healthcare plans, impacting over 72 million Americans. Advocates have long criticized the lack of transparency, calling for changes that this regulation seeks to address.